“Attenuating Renal Interstitial Fibrosis by Shenqi Pill via Reducing Inflammation Response Regulated by NF-κB Pathway In Vitro and In Vivo” (2024) Iranian Journal of Kidney Diseases, 18(2), pp. 87–98. doi:10.52547/ggc27334.